18F-FDG正电子显像质量保证

贺小红

引用本文:
Citation:

18F-FDG正电子显像质量保证

  • 中图分类号: R817.4

Quality assurance of 18F-FDG positron imaging

  • CLC number: R817.4

  • 摘要: 18F-FDG(18F-氟代脱氧葡萄糖)正电子显像(包括传统的PET和符合线路显像)的重要价值已为大量临床研究所证实,但其结果的影响因素比较复杂。本文就仪器验收和日常质量控制、检查前准备、数据采集和处理,以及结果分析等方面,介绍18F-FDG正电子显像的质量保证措施。
  • [1] IAEA-TECDOC-602,Quality Control of Nuclear Medicine Instruments[S].
    [2] NEMA Standards Publication NU 2-2001,Performance Measurements of Positron Emission Tomographs.National Electrical Manufacturers Association[S].
    [3] NEMA Standards Publication NU 1-2001,Performance Measurements of Scintillation Cameras.National Electrical Manufacturers Association[S].
    [4] Interenational Electrotechnical Commission (IEC)61675-1,Rodi-onuelide imaging devices-daracteristics and test conditions part 1:Positro emission tomographs[S].
    [5] Tatsumi M,Clark PA,Nakamoto Y,et al.Impact of body habitus on quantitative and qualitative image quality in whole-body FDG-PET[J],Eur J Nucl Med Mol Imag,2003,30(1):40-45.
    [6] Lartizien C,Comtat C,Kinahan PE,et al.Optimization of injected dose based on noise equivalent count rates for 2-and 3-dimensional whole-body PET[J].J Nucl Med,2002,43(9):1268-1278.
    [7] Kubota K,Itoh M,Ozaki K,et al.Advantage of delayed whole-body FdG PET imaging for tumour detection[J].Eur J Nucl Med,2001,28(6):696-703.
    [8] Demura Y,Tsuchida T,Ishizaki T,et al.18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax[J].J Nucl Med,2003,44(4):540-548.
    [9] Boerner AR,Weckesser M,Herzog H,et al.Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer[J].Eur J Nucl Med,1999,26(3):226-230.
    [10] Kadrmas DJ,Christian PE.Comparative evaluation of lesion detectability for 6 PET imaging platforms using a highly reproducible whole-body phantom with (22)Na lesions and localization ROC analysis[J].J Nucl Med,2002,43(11):1545-1554.
    [11] Bettinardi V,Pagani E,Gilardi MC.Implementation and evaluation of a 3D one-step late reconstruction algorithm for 3D positron emission tomography brain studies using median root prior[J].Eur J Nucl Med Mol Imag,2002,29(1):7-18.
    [12] Lartizien C,Kinahan PE,Swensson R,et al.Evaluating image reconstruction methods for tumor detection in 3-dimensional whole-body PET oncology imaging[J].J Nucl Med,2003,44(2):276-290.
    [13] Zaidi H.Reconstruction-based estimation of the scatter component in positron emission tomography[J].Ann Nucl Med Sci,2001,14:161-172.
    [14] Ak I,Blokland JA,Pauwels EK,et al.The clinical valve of 18F-FDG detection with a dual-head coincidence camera:a review[J].Eur J Nucl Med,2001,28(6):763-778.
    [15] Zaidi H,Hasegawa B.Determination of the attenuation map in emission tomography[J].J Nucl Med,2003,44(2):291-315.
    [16] Nakamoto Y,Osman M,Cohade C,et al.PET/CT:comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images[J].J Nucl Med,2002,43(9):1137-1143.
    [17] Osman MM,Cohade C,Nakamoto Y,et al.Clinically significant inaccurate localization of lesions with PET/CT:frequency in 300 patients[J].J Nucl Med,2003,44(2):240-243.
    [18] Beyer T,Townsend DW,Brun T,et al.A conbined PET/CT scanner for clinical oncology[J].J Nucl Med,2000,41:1369-1379.
    [19] Goerres GW,Kamel E,Heidelberg TN,et al.PET-CT image coregistration in the thorax:influence of respiration[J].Eur J Nucl Med Mol Imag,2002,29(3):351-360.
    [20] Giraud P,Grahek D,Montravers F,et al.CT and (18)F-deoxyglu-cose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers[J].Int J Radiat Oncol Biol Phys,2001,49(5):1249-1257.
    [21] Karger CP,Hipp P,Henze M,et al.Stereotactic imaging for radiotherapy:accuracy of CT,MRI,PET and SPECT[J].Phys Med Biol,2003,48(2):211-221.
  • [1] 江波刘振宅徐晓 . 调强放疗中有关多叶准直器的质量保证与质量控制. 国际放射医学核医学杂志, 2006, 30(6): 378-381.
    [2] 涂彧 . 普通X射线诊断设备的质量控制. 国际放射医学核医学杂志, 2000, 24(1): 38-43.
    [3] 尉可道 . 医用诊断X射线的影像质量与病人剂量评价研究进展. 国际放射医学核医学杂志, 1997, 21(z1): 240-243.
    [4] 王劲程亮唐明灯庄达君 . (N-[18F]氟甲基)胆碱的合成与质量控制. 国际放射医学核医学杂志, 2014, 38(3): 171-174. doi: 10.3760/cma.j.issn.1673-4114.2014.03.008
    [5] 涂彧 . 乳房X射线成像术的质量控制. 国际放射医学核医学杂志, 2000, 24(1): 35-38.
    [6] 钟建国夏振民王思理 . 美国PET放射性药物的生产和质量控制管理. 国际放射医学核医学杂志, 1999, 23(5): 198-202.
    [7] 冯仲苏徐晓刘芬192Ir高剂量率后装治疗剂量准确性的质量控制. 国际放射医学核医学杂志, 2008, 32(6): 376-378.
    [8] 拓飞张庆张京周强李文红徐翠华苏旭 . 2014年度全国放射性核素γ能谱分析质量控制比对. 国际放射医学核医学杂志, 2015, 39(5): 401-404. doi: 10.3760/cma.j.issn.1673-4114.2015.05.011
    [9] 张奇洲李毓斌李肖红秦永德11C-乙酸盐的自动化合成影响因素的考察及质量控制. 国际放射医学核医学杂志, 2016, 40(1): 6-12. doi: 10.3760/cma.j.issn.1673-4114.2016.01.002
    [10] 赵鑫李光朋翟贺争蔡勋明 . 辽宁省2021—2022年医用数字X射线摄影质量控制检测结果分析. 国际放射医学核医学杂志, 2023, 47(4): 229-235. doi: 10.3760/cma.j.cn121381-202208009-00278
  • 加载中
计量
  • 文章访问数:  1407
  • HTML全文浏览量:  197
  • PDF下载量:  3
出版历程
  • 收稿日期:  2003-12-30

18F-FDG正电子显像质量保证

  • 528000 广东佛山, 广东省佛山市第一人民医院核医学科

摘要: 18F-FDG(18F-氟代脱氧葡萄糖)正电子显像(包括传统的PET和符合线路显像)的重要价值已为大量临床研究所证实,但其结果的影响因素比较复杂。本文就仪器验收和日常质量控制、检查前准备、数据采集和处理,以及结果分析等方面,介绍18F-FDG正电子显像的质量保证措施。

English Abstract

参考文献 (21)

目录

    /

    返回文章
    返回